Know Cancer

or
forgot password

Invasiveness and Chemoresistance of Cancer Stem Cells in Colon Cancer: Molecular Characterization and Implications for Therapeutic Strategies


N/A
18 Years
N/A
Open (Enrolling)
Both
Colorectal Neoplasms

Thank you

Trial Information

Invasiveness and Chemoresistance of Cancer Stem Cells in Colon Cancer: Molecular Characterization and Implications for Therapeutic Strategies


Secondary objectives include:

- Determine the intrinsic properties essential for the dissemination and chemoresistance
of these cells capable of initiating tumors

- Identify a "molecular signature" for potential invasiveness and chemoresistance of
cells initiating metastases.

- Describe the evolution of patients during 24 months of follow up and correlations with
observed cellular profiles.

- Enrich the tumor bank of the institution.


Inclusion Criteria:



- The patient must have given his/her informed and signed consent

- The patient must be insured or beneficiary of a health insurance plan

- Patient with adenocarcinoma-type colorectal cancer:

- stage III at diagnosis, surgical resection of the primary tumor proposed.

- stage IV at diagnosis, surgical resection of the primary tumor and possibly of
metastases proposed.

- Stage IV who have already undergone surgical excision of the primary tumor, and for
whom metastasectomy is now proposed.

Exclusion Criteria:

- The patient is participating in another study

- The patient is in an exclusion period determined by a previous study

- The patient is under judicial protection, under tutorship or curatorship

- The patient refuses to sign the consent

- It is impossible to correctly inform the patient

- Patients for whom surgical resection of the primary tumor is not considered as an
option

- PStage IV at diagnosis, but metastasectomy is not considered as an option

- Patients with positive HIV, Hepatitis B or Hepatitis C serology

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Ability to maintain the cells isolated from colorectal tumors in culture or 3D collagen matrices and then infect these cells to make them express reporter genes: yes/no.

Outcome Time Frame:

Baseline (Day 0)

Safety Issue:

No

Principal Investigator

Jean-François Bourgaux, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Centre Hospitalier Universitaire de Nîmes

Authority:

France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)

Study ID:

LOCAL/2011/JFB-01

NCT ID:

NCT01577511

Start Date:

May 2012

Completion Date:

June 2015

Related Keywords:

  • Colorectal Neoplasms
  • invasive potential
  • molecular characterisation of circulating cells
  • Neoplasms
  • Colonic Neoplasms
  • Colorectal Neoplasms

Name

Location